| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.084 | 0.05 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |